BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3085299)

  • 1. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.
    Cobbold S; Waldmann H
    Transplantation; 1986 May; 41(5):634-9. PubMed ID: 3085299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
    Wheelahan J; McKenzie IF
    Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of T lymphocyte subsets in antiviral host defense.
    Leist TP; Cobbold SP; Waldmann H; Aguet M; Zinkernagel RM
    J Immunol; 1987 Apr; 138(7):2278-81. PubMed ID: 2435794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
    Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
    J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection.
    LeFrancois L; Bevan MJ
    J Exp Med; 1984 Jan; 159(1):57-67. PubMed ID: 6198428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells.
    Müller I; Cobbold SP; Waldmann H; Kaufmann SH
    Infect Immun; 1987 Sep; 55(9):2037-41. PubMed ID: 3114143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo.
    Sprent J; Schaefer M; Lo D; Korngold R
    Immunol Rev; 1986 Jun; 91():195-218. PubMed ID: 2942460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
    Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
    Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells.
    Warren HS; Pembrey RG
    Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
    Loveland BE; Hogarth PM; Ceredig R; McKenzie IF
    J Exp Med; 1981 May; 153(5):1044-57. PubMed ID: 7019377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution (C57BL/10Sn + B10.D2/nSn----C57BL/10Sn).
    Ildstad ST; Bluestone JA; Sachs DH
    J Exp Med; 1986 May; 163(5):1343-8. PubMed ID: 2939173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: a flowcytometric and immunohistological analysis.
    van Vliet E; Melis M; van Ewijk W
    Cell Immunol; 1986 Dec; 103(2):229-40. PubMed ID: 2879639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.
    Bhan AK; Mihm MC; Dvorak HF
    J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
    Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
    Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.